CYT_ONCKE
ID CYT_ONCKE Reviewed; 130 AA.
AC Q98967;
DT 15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT 15-DEC-1998, sequence version 2.
DT 25-MAY-2022, entry version 86.
DE RecName: Full=Cystatin {ECO:0000303|PubMed:7764512};
DE Flags: Precursor;
OS Oncorhynchus keta (Chum salmon) (Salmo keta).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Actinopterygii; Neopterygii; Teleostei; Protacanthopterygii; Salmoniformes;
OC Salmonidae; Salmoninae; Oncorhynchus.
OX NCBI_TaxID=8018;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], SYNTHETIC PEPTIDE 20-35, SUBCELLULAR LOCATION,
RP AND TISSUE SPECIFICITY.
RC TISSUE=Liver {ECO:0000303|PubMed:8902609};
RX PubMed=8902609; DOI=10.1093/oxfordjournals.jbchem.a021438;
RA Yamashita M., Konagaya S.;
RT "Molecular cloning and gene expression of chum salmon cystatin.";
RL J. Biochem. 120:483-487(1996).
RN [2]
RP PROTEIN SEQUENCE OF 20-130, FUNCTION, AND DISULFIDE BONDS.
RC TISSUE=Pituitary {ECO:0000303|PubMed:7764512};
RX PubMed=7764512; DOI=10.1271/bbb.58.164;
RA Koide Y., Noso T.;
RT "The complete amino acid sequence of pituitary cystatin from chum salmon.";
RL Biosci. Biotechnol. Biochem. 58:164-169(1994).
CC -!- FUNCTION: Cysteine proteinase inhibitor. {ECO:0000269|PubMed:7764512}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:8902609}.
CC -!- TISSUE SPECIFICITY: Ubiquitous expression including brain, white
CC muscle, heart, gill, kidney, spleen, liver and skin with the highest
CC and lowest level in brain and gill, respectively.
CC {ECO:0000269|PubMed:8902609}.
CC -!- SIMILARITY: Belongs to the cystatin family. {ECO:0000305}.
CC -!- SEQUENCE CAUTION:
CC Sequence=BAA13149.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; D86628; BAA13149.1; ALT_INIT; mRNA.
DR PIR; JC2040; JC2040.
DR AlphaFoldDB; Q98967; -.
DR SMR; Q98967; -.
DR MEROPS; I25.041; -.
DR GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR GO; GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR GO; GO:0030414; F:peptidase inhibitor activity; ISS:AgBase.
DR CDD; cd00042; CY; 1.
DR InterPro; IPR000010; Cystatin_dom.
DR InterPro; IPR046350; Cystatin_sf.
DR InterPro; IPR018073; Prot_inh_cystat_CS.
DR Pfam; PF00031; Cystatin; 1.
DR SMART; SM00043; CY; 1.
DR SUPFAM; SSF54403; SSF54403; 1.
DR PROSITE; PS00287; CYSTATIN; 1.
PE 1: Evidence at protein level;
KW Direct protein sequencing; Disulfide bond; Protease inhibitor; Secreted;
KW Signal; Thiol protease inhibitor.
FT SIGNAL 1..19
FT /evidence="ECO:0000269|PubMed:7764512"
FT CHAIN 20..130
FT /note="Cystatin"
FT /id="PRO_0000006665"
FT MOTIF 67..71
FT /note="Secondary area of contact"
FT /evidence="ECO:0000250|UniProtKB:P04080"
FT SITE 23
FT /note="Reactive site"
FT /evidence="ECO:0000250|UniProtKB:P04080"
FT DISULFID 85..94
FT /evidence="ECO:0000269|PubMed:7764512"
FT DISULFID 108..128
FT /evidence="ECO:0000269|PubMed:7764512"
FT CONFLICT 22
FT /note="V -> I (in Ref. 2; AA sequence)"
FT /evidence="ECO:0000305"
FT CONFLICT 115
FT /note="R -> I (in Ref. 2; AA sequence)"
FT /evidence="ECO:0000305"
FT CONFLICT 120
FT /note="D -> G (in Ref. 2; AA sequence)"
FT /evidence="ECO:0000305"
FT CONFLICT 122
FT /note="Q -> K (in Ref. 2; AA sequence)"
FT /evidence="ECO:0000305"
SQ SEQUENCE 130 AA; 14566 MW; 099BBCC8A998C2D7 CRC64;
MEWKIVVPLL AVAFTVANAG LVGGPMDANM NDQGTRDALQ FAVVEHNKKT NDMFVRQVAK
VVNAQKQVVS GMKYIFTVQM GRTPCRKGGV EKICSVHKDP QMAVPYKCTF EVWSRPWMSD
IQMVKNQCES